Not every workplace drug testing program has the same objectives. That’s why deciding whether to include fentanyl screening should begin with understanding your organization's specific needs.
For some employers, a standard drug testing panel may be appropriate based on workplace policies and risk considerations. For others, expanded panel configurations that include fentanyl may better align with operational goals, industry expectations, or internal safety initiatives.
Organizations in healthcare, behavioral health, recovery services, public safety, transportation, and other safety-sensitive industries often evaluate broader testing options as part of their overall drug screening strategy. Community organizations and treatment programs may also consider fentanyl screening depending on the populations they serve and the purpose of their testing program.
The decision is not simply about adding another substance to a panel. It is about ensuring that the testing program reflects the organization's policies, workplace environment, and screening objectives.
As drug testing technology continues to evolve, reviewing panel configurations periodically helps ensure your program remains aligned with current needs rather than relying on assumptions or outdated testing practices.
Every organization is different, which is why there is no universal answer. The most effective programs are built around informed decisions supported by clear policies and appropriate testing options.
Fact Friday takeaway:
Fentanyl screening makes the most sense when it aligns with your organization's workplace risks, policies, and overall drug testing objectives.
Using a credible resource for drug screening supplies helps support consistency and reliability across your program.
